Cargando…
Common molecular signatures between coronavirus infection and Alzheimer’s disease reveal targets for drug development
Cognitive decline has been reported as a common consequence of COVID-19, and studies have suggested a link between COVID-19 infection and Alzheimer’s disease (AD). However, the molecular mechanisms underlying this association remain unclear. To shed light on this link, we conducted an integrated gen...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10312734/ https://www.ncbi.nlm.nih.gov/pubmed/37398415 http://dx.doi.org/10.1101/2023.06.14.544970 |